saw103

Scott A.. Waldman, MD, PhD

Contact Dr. Waldman

132 South 10th Street
Suite 1170
Philadelphia, PA 19107

(215) 955-6086
(215) fax

Most Recent Peer-reviewed Publications

  1. Peer Review Certifies Quality and Innovation in Clinical Pharmacology & Therapeutics
  2. Bioactivity of oral linaclotide in human colorectum for cancer chemoprevention
  3. Guanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer
  4. Prime-boost immunization eliminates metastatic colorectal cancer by producing high-Avidity effector CD8+ T cells
  5. Clinical Pharmacology & Therapeutics: Past, Present, and Future
  6. Cardiopoietic cell therapy for advanced ischaemic heart failure: Results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial
  7. EXECUTIVE INTERVIEW - Viral gene: Protein-targeting cancer vaccine could boost survival rates
  8. Preclinical Evaluation of a Replication-Deficient Recombinant Adenovirus Serotype 5 Vaccine Expressing Guanylate Cyclase C and the PADRE T-helper Epitope
  9. A survey of physician receptivity to molecular diagnostic testing and readiness to act on results for early-stage colon cancer patients
  10. Guanylyl cyclase C signaling axis and colon cancer prevention
  11. Guanylyl cyclase C hormone axis at the intersection of obesity and colorectal cancer
  12. Targeting guanylate cyclase C in colorectal cancer: Where are we now?
  13. GUCY2C ligand replacement to prevent colorectal cancer
  14. Big data transforms discoveryutilization therapeutics continuum
  15. Obesity-induced colorectal cancer is driven by caloric silencing of the guanylin-GUCY2C paracrine signaling axis
  16. Bioinnovation Enterprise: An Engine Driving Breakthrough Therapies
  17. Intestinal enteroids model guanylate cyclase C-dependent secretion induced by heat-stable enterotoxins
  18. Guanylyl cyclase C as a biomarker
  19. CD19-targeted nanodelivery of doxorubicin enhances therapeutic efficacy in B-cell acute lymphoblastic leukemia
  20. Clinical pharmacology & therapeutics: The next five years